Rosalind Franklin University of Medicine and Science Breaks Ground On New Science Park
Published: Sep 11, 2017
NORTH CHICAGO, Ill., Sept. 8, 2017 /PRNewswire-USNewswire/ -- Rosalind Franklin University of Medicine and Science celebrated the impending construction of its new Innovation and Research Park with a ceremonial groundbreaking on Sept. 8 attended by state and local officials, life science industry partners, and university faculty, alumni and supporters.
The research park, which will be built on the university's campus in Lake County, home to the largest concentration of bioscience companies in the Midwest, will offer a collaborative environment for academic and industry scientists, innovators and entrepreneurs, with the goal of accelerating RFU's nationally recognized research into treatment and prevention of disease. It will provide state-of-the-art laboratories and spaces for faculty and commercial startups and small- to mid-size national and international biotech firms.
"This new science park places innovative medical science very close to global pharmaceutical and medical device leaders and that proximity will accelerate the translation of new medical discoveries into improved therapy and diagnostics," said RFU President and CEO Dr. K. Michael Welch. "It's evidence of our university's commitment to put our science to work improving health and well-being, especially among our local communities that carry unequal burdens of illness and disease."
RFU investigators conduct biomedical research in 12 major areas, including cardiac resuscitation, cancer, drug discovery and development, cystic fibrosis, neuroscience and neurodegenerative diseases such as Alzheimer's and Parkinson's.
"Our researchers are excited about the possibility of new collaborations with industry experts that can help translate their science into therapeutics to benefit patients at home and around the globe," said Ronald Kaplan, PhD, RFU executive vice president for research. "This expansion of our research beyond our laboratories, into actual development, can help save lives, improve health care and help grow our local and regional economy."
The expansion will consist of 100,000 square feet of state-of-the-art research, office and meeting space that will ultimately house 175 scientists, including investigators in industries collaborating with the university. RFU will occupy approximately two-thirds of the building. Remaining space will be leased to life science companies.
Job creation, job training programs and internships are also components of the vision for the park, which is expected to generate an estimated 500 direct new jobs. A study by Lake County Partners forecasts a total economic regional impact of $117 million per year.
"Lake County is already a favored location for life science activity and jobs and the development of the new Rosalind Franklin University science park will further enhance our cluster and create additional space for international life science companies to land in Illinois," said Kevin Considine, Lake County Partners president and CEO.
The $50 million construction will be financed through a recent bond sale that generated in excess of $1 billion in interest, according to the Atlanta-based developer for the project, The University Financing Foundation (TUFF). Terms of the funding agreement also include a beneficial refinancing of existing debt and a long-term ground lease and master lease. TUFF has extensive experience in building science parks throughout the United States and assisting universities in financing and expanding their infrastructure.
"The Innovation and Research Park will help the university grow its impressive research capabilities, including its new company formation and medical entrepreneurship," said TUFF President Kevin Byrne. "It will enhance collaboration between academic scientists and industry innovators and that's a proven approach to speeding the translation of discoveries into life-saving treatments."
RFU is working with the SmartHealth Activator, a Lake County-based incubator focused on the commercialization of biotechnology coming out of Midwest universities, to increase the number of new companies formed by RFU faculty entrepreneurs.
"There is extraordinary biotech being developed at RFU," said Tom Denison, SmartHealth president. "We are passionate about facilitating success for strong teams intent on solving significant health problems. The university's proximity to some of the nation's top healthcare companies and the people who built them offers important access to elite mentors, experienced operators and investors."
The science park is based in a public-private partnership that, in addition to RFU and TUFF, includes the City of North Chicago, Lake County, and the Illinois Department of Commerce and Economic Opportunity.
"North Chicago has great expectations for this science park in both economic development impact and providing future careers for our students to aim for," said North Chicago Mayor Leon Rockingham. "Rosalind Franklin University is a leader in our community in offering healthcare to the underserved and in mentoring and building academic pipelines for our students. We see the new science park as an extension of that commitment."
Completion of the new building is expected in summer 2019. The university's campus is located directly south of the Capt. James A. Lovell Federal Health Care Center, its longtime clinical and research partner.
About Rosalind Franklin University of Medicine and Science
A national leader in interprofessional healthcare education and biomedical and clinical research, Rosalind Franklin University brings together more than 30 graduate health professions and science programs on a single campus, allowing for a wealth of team-based, interdisciplinary learning and practice opportunities. RFU includes the Chicago Medical School, College of Health Professions, College of Pharmacy, Dr. William M. Scholl College of Podiatric Medicine, and the School of Graduate and Postdoctoral Studies. More than 18,000 RFU degreed alumni are active throughout the United States and around the world. For more information, visit www.rosalindfranklin.edu.
The University Financing Foundation (TUFF) is a nonprofit 501(c)(3) operating foundation that assists institutions of education and research in the planning, development, and financing of facilities and equipment at below-market costs.
SmartHealth Activator provides biotech startups access to customers, elite mentors, experienced operators, investors, seed funding and co-working space.
CONTACT: Judith Masterson, 847-578-8313, firstname.lastname@example.org
SOURCE Rosalind Franklin University of Medicine and Science